AI MARKET SCANNING

Apogee Therapeutics, Inc.

🏛️ NASDAQ 📁 Healthcare 🏭 Biotechnology
AVG HISTORICAL GAP +6.40%
MAX GAP RECORD +43.53%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $APGE
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 10, 2026 Earnings Release 2026-08-10 (UNDETERMINED)
+0.00%
May 11, 2026 Earnings Release 2026-05-11 (UNDETERMINED)
+0.00%
Mar 02, 2026 Earnings Release 2026-03-02 (UNDETERMINED)
+0.00%
Nov 10, 2025 Earnings Release 2025-11-10 (AFTER CLOSE)
-0.12%
Aug 11, 2025 Earnings Release 2025-08-11 (AFTER CLOSE)
+1.39%
May 12, 2025 Earnings Release 2025-05-12 (BEFORE OPEN)
+5.90%
Mar 03, 2025 Earnings Release 2025-03-03 (BEFORE OPEN)
+3.88%
Nov 12, 2024 Earnings Release 2024-11-12 (BEFORE OPEN)
-0.36%

VOLATILITY & GAP BIAS

AVG GAP MOVE 7.3%
Bullish Gaps (4)
Bearish Gaps (2)
Neutral / Flat (2)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $APGE

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis, asthma, eosinophilic esophagitis, chronic obstructive pulmonary disease, and other inflammatory and immunology indications in the United States. The company develops Zumilokibart (APG777), a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for the treatment…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗